Latest California Healthline Stories
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
The Food and Drug Administration rarely prosecutes research violations, but its criminal division is looking into the experimental herpes vaccine research by Southern Illinois University professor William Halford.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
Southern Illinois University’s ethics panel launches “full” inquiry into herpes vaccine experiments on human subjects that took place offshore and in the U.S. without proper oversight by one of its professors, who has since died.
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.